Guangzhou Boji Medical and Biotechnology Co.,Ltd. (known as Boji biomedicals with the stock code of 300404) was founded in 2002 and listed on Shenzhen GEM in 2015. Boji is a new high-tech enterprise(CRO+CDMO) that provides one-stop service for domestic and abroad pharmaceutical enterprises, such as the R&D of drugs, medical devices and health products. Headquartered in the wisdom city of Tianhe District in Guangzhou, the company has gathered nearly 800 biomedical R&D talents and registered legislative experts with an area of nearly 3000 square meters. The company owns 9 wholly-owned subsidiaries with different business and more than 10 holding and shareholding companies.
The one-stop service provided by Boji includes approval of new drugs project and activity screening, pharmaceutical research of active pharmaceutical ingredient (API) and preparations, drug evaluation (pharmacodynamics, toxicology). Besides, clinical research, sino American (registration service), contract development & manufacturing organization (CDMO), the commercialization of technology achievements are included, covering all stages of new drug research and development.MORE +
Honest and trustworthy,
make progress with Customers.
Service is fundamental, quality is life.
Consolidate domestic leadership, achieve international leadership and build a century-old brand.
Think for customers, serve customers and make progress together with customers.
Build a professional, honest, enterprising and harmonious Boji family.
Tong Ren Tong
Pien Tze Huang
Sun Yat-sen University